| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $82,811,774 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI153246 | ZBP1 activation | 000 | 5 | NIH | 3/21/2025 | $580,839 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI150152 | Mechanism of the Fluoroquinolone Resistance Acquisition in Enterobacteria | 000 | 5 | NIH | 3/21/2025 | $692,046 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K01DK128128 | Activation of C/EBP-β by mitohormesis as a therapy for obesity | 000 | 4 | NIH | 2/17/2025 | $146,750 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DC019352 | Reducing social isolation for adults with chronic communication disabilities | 000 | 5 | NIH | 3/21/2025 | $277,382 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI155416 | Regulation of RNA sensing and viral restriction by RNA structures | 000 | 3 | NIH | 2/25/2025 | $428,013 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI188716 | Single-cell transcriptional atlas of Giardia encystation | 000 | 1 | NIH | 2/24/2025 | $218,767 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI183692 | Molecular determinants and functions of bacterial polysaccharide cellular localization | 000 | 1 | NIH | 2/25/2025 | $783,557 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI179768 | Development of dual effective kinase inhibitors as syndromic treatment of Giardiasis and Cryptosporidiosis | 000 | 2 | NIH | 3/5/2025 | $746,285 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AR074417 | Causal Genes at BMD Loci | 000 | 5 | NIH | 3/27/2025 | $369,690 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG078279 | Aging Mitochondrial Interactome | 000 | 3 | NIH | 3/6/2025 | $490,561 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH130336 | Kinase Dysfunction in Autism and Neurodevelopmental Disorders | 000 | 3 | NIH | 3/6/2025 | $626,439 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08EY033789 | The role of non-coding variants in Usher disease | 000 | 3 | NIH | 3/26/2025 | $230,277 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K01DK128126 | Investigation into the role of autophagy protease ATG4A in normal and impaired erythropoiesis | 000 | 5 | NIH | 2/19/2025 | $148,014 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R03DE033779 | Microbiome Analysis of Plaque Samples from a Community-Based Socio-behavioral RCT to Reduce Sugared Fruit Drinks in Alaska Native Children | 000 | 2 | NIH | 3/26/2025 | $139,950 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01HG011744 | University of Washington Mendelian Genomics Research Center (UW-MGRC) | 000 | 5 | NIH | 3/26/2025 | $2,390,073 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258997 | Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays | 001 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01EY035647 | Noncontact in vivo guidance of corneal collagen crosslinking therapy with optical coherence tomography and acoustic micro-tapping elastography | 000 | 2 | NIH | 2/14/2025 | $608,808 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R37DA033396 | DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCE | 000 | 13 | NIH | 3/24/2025 | $388,454 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HD101422 | Repurposing Azithromycin for premature brain injury | 000 | 5 | NIH | 2/14/2025 | $432,741 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | D43TW011817 | Tuberculosis & HIV Co-Infection Training Program in Kenya | 000 | 5 | NIH | 3/10/2025 | $236,554 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | D43TW011817 | Tuberculosis & HIV Co-Infection Training Program in Kenya | 000 | 5 | NIH | 3/10/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01MH135901 | Developing Data-Driven Clinical Signatures for People Who Experience Hallucinations | 000 | 2 | NIH | 3/11/2025 | $2,139,265 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI177874 | The Differentiation and Function of heterogeneous populations of Allergen-specific Lung-resident Th2 CD4+ memory cells | 000 | 2 | NIH | 3/11/2025 | $841,731 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG071024 | Short and long-term consequences of wildfires for Alzheimer's disease and related dementias | 000 | 4 | NIH | 3/11/2025 | $552,587 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UG1DA013714 | Clinical Trials Network: Pacific Northwest Node | 002 | 24 | NIH | 2/21/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01DE030418 | Understanding Oral Diseases in Cystic Fibrosis to Develop Tailored Preventive Dental Interventions | 001 | 5 | NIH | 3/11/2025 | $572,837 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | NU2GGH002242 | Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) | 06 | 5 | CDC | 2/28/2025 | $1,752,104 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | NU2GGH002242 | Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) | 06 | 5 | CDC | 2/28/2025 | $2,415,862 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | NU2GGH002242 | Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) | 06 | 5 | CDC | 2/28/2025 | $9,222 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA254515 | Rural Community Support for Colonoscopy | 000 | 5 | NIH | 3/4/2025 | $462,866 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 3/4/2025 | $621,600 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 000 | 6 | NIH | 3/4/2025 | $1,906,189 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI183320 | Altered protein structures and neoepitopes in lupus neutrophils from dysregulated splicing of messenger RNA | 000 | 1 | NIH | 3/21/2025 | $256,808 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01NS122766 | Novel approaches to identify tandem repeat expansions in neurodegenerative disease | 000 | 4 | NIH | 3/21/2025 | $349,875 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00ES031050 | A systematic study of the environmental etiology of autism spectrum disorder using high-throughput behavioral screening | 001 | 5 | NIH | 3/21/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01EY033731 | IMPDH1 in photoreceptor function and disease | 000 | 2 | NIH | 2/14/2025 | $411,390 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258352 | Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging | 001 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI147504 | Drug Discovery for Chagas Disease | 002 | 6 | NIH | 3/22/2025 | $839,338 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01GM148741 | Development of Analytical Tools for Concentration and Real-Time Control of Dissolved Gases and Their Regulation of Tissue Function | 000 | 3 | NIH | 3/25/2025 | $437,715 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01EY035921 | Neurophysiology of Disjunctive Saccades | 000 | 2 | NIH | 2/14/2025 | $847,967 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA260825 | TLR7/8 agonist design and delivery for effective anticancer immune response | 001 | 5 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01NS091056 | Quantifying patient-specific changes in neuromuscular control in cerebral palsy | 000 | 9 | NIH | 3/24/2025 | $351,166 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258606 | Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy | 001 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI182705 | Discovery of fungus-derived natural products as new and effective Antigiardial agents. | 000 | 2 | NIH | 2/28/2025 | $200,086 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R61MH132809 | Developing a Digital Just-in-Time Adaptive Intervention for Adolescent Depression Treatment in Primary Care | 001 | 2 | NIH | 3/8/2025 | $719,514 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01GM123062 | Understanding How Thiolates Promote Dioxygen Chemistry | 000 | 8 | NIH | 3/24/2025 | $384,918 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U24NS100654 | University of Washington HUB Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) | 000 | 8 | NIH | 3/24/2025 | $191,519 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U24NS100654 | University of Washington HUB Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) | 000 | 8 | NIH | 3/24/2025 | $153,214 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258298 | Characterizing, optimizing, and harmonizing cancer detection with PET imaging | 001 | 4 | NIH | 2/14/2025 | $0 |
|
